{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:35:24Z","timestamp":1794335724032,"version":"4.9.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008436","name":"National Foundation for Medical Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1122897"],"award-info":[{"award-number":["1122897"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1154347"],"award-info":[{"award-number":["1154347"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.vaccine.2023.05.032","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T13:32:03Z","timestamp":1684848723000},"page":"3976-3988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A booster regime of liposome-delivered live-attenuated CHIKV vaccine RNA genome protects against chikungunya virus disease in mice"],"prefix":"10.1016","volume":"41","author":[{"given":"Shambhavi","family":"Rao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eranga","family":"Abeyratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kothila","family":"Tharmarajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Mostafavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehfuz","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Mahalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Zaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2023.05.032_b0005","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1172\/JCI84417","article-title":"Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies","volume":"127","author":"Silva","year":"2017","journal-title":"J Clin Invest"},{"issue":"suppl 5","key":"10.1016\/j.vaccine.2023.05.032_b0010","doi-asserted-by":"crossref","first-page":"S449","DOI":"10.1093\/infdis\/jiw382","article-title":"How Chikungunya Virus Virology Affects Its Epidemiology and Transmission: Implications for Influencing Public Health","volume":"214","author":"Powers","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.05.032_b0015","series-title":"The arboviruses: epidemiology and ecology","author":"Monath","year":"2021"},{"issue":"suppl 5","key":"10.1016\/j.vaccine.2023.05.032_b0020","doi-asserted-by":"crossref","first-page":"S436","DOI":"10.1093\/infdis\/jiw391","article-title":"Chikungunya: its history in Africa and Asia and its spread to new regions in 2013\u20132014","volume":"214","author":"Zeller","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.05.032_b0025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijid.2017.03.006","article-title":"Global expansion of chikungunya virus: mapping the 64-year history","volume":"58","author":"Wahid","year":"2017","journal-title":"Int J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2023.05.032_b0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MD\/0b013e31806010a5","article-title":"Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases","volume":"86","author":"Simon","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.vaccine.2023.05.032_b0035","unstructured":"World Health Organization. Regional Office for South-East A. Guidelines on clinical management of chikungunya fever. New Delhi: WHO Regional Office for South-East Asia; 2008 2008."},{"key":"10.1016\/j.vaccine.2023.05.032_b0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40942-016-0057-4","article-title":"Arboviruses and the eye","volume":"3","author":"de Andrade","year":"2017","journal-title":"Int J Retina Vitreous"},{"issue":"3","key":"10.1016\/j.vaccine.2023.05.032_b0045","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11908-011-0180-1","article-title":"Chikungunya virus infection","volume":"13","author":"Simon","year":"2011","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.vaccine.2023.05.032_b0050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijid.2015.07.015","article-title":"Burden of chikungunya in Latin American countries: estimates of disability-adjusted life-years (DALY) lost in the 2014 epidemic","volume":"38","author":"Cardona-Ospina","year":"2015","journal-title":"Int J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2023.05.032_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009055","article-title":"Measuring the global burden of chikungunya and Zika viruses: A systematic review","volume":"15","author":"Puntasecca","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2023.05.032_b0060","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3201\/eid1403.070720","article-title":"Increased mortality rate associated with chikungunya epidemic, Ahmedabad","volume":"14","author":"Mavalankar","year":"2008","journal-title":"India Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2023.05.032_b0065","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3201\/eid1402.071024","article-title":"Chikungunya fever, Mauritius, 2006","volume":"14","author":"Beesoon","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2023.05.032_b0070","unstructured":"Organization. PAH. Number of Reported Cases of Chikungunya Fever in the Americas, by Country or Territory 2013-2014 (Updated 23 Oct 2015) 2015 [Available from: https:\/\/www.paho.org\/hq\/dmdocuments\/2015\/2015-may-15-cha-CHIKV-cumulative-cases.pdf."},{"issue":"3","key":"10.1016\/j.vaccine.2023.05.032_b0075","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4049\/jimmunol.107.3.643","article-title":"Production and evaluation of a formalin-killed Chikungunya vaccine","volume":"107","author":"Harrison","year":"1971","journal-title":"J Immunol"},{"issue":"18","key":"10.1016\/j.vaccine.2023.05.032_b0080","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1016\/j.vaccine.2009.02.062","article-title":"Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus","volume":"27","author":"Tiwari","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2023.05.032_b0085","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1128\/am.19.2.321-325.1970","article-title":"Chikungunya virus vaccine prepared by Tween-ether extraction","volume":"19","author":"Eckels","year":"1970","journal-title":"Appl Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2023.05.032_b0090","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4269\/ajtmh.2000.62.681","article-title":"Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218","volume":"62","author":"Edelman","year":"2000","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.032_b0095","first-page":"e01970","article-title":"Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein","volume":"8","author":"Taylor","year":"2017","journal-title":"Implications for Vaccine Design mBio"},{"issue":"39","key":"10.1016\/j.vaccine.2023.05.032_b0100","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1016\/j.vaccine.2008.07.054","article-title":"Chimeric alphavirus vaccine candidates for chikungunya","volume":"26","author":"Wang","year":"2008","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2023.05.032_b0105","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/j.vaccine.2011.01.108","article-title":"A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.032_b0110","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/1743-422X-8-353","article-title":"Functional processing and secretion of Chikungunya virus E1 and E2 glycoproteins in insect cells","volume":"8","author":"Metz","year":"2011","journal-title":"Virol J"},{"issue":"16","key":"10.1016\/j.vaccine.2023.05.032_b0115","doi-asserted-by":"crossref","first-page":"8879","DOI":"10.1128\/JVI.00370-12","article-title":"A specific domain of the Chikungunya virus E2 protein regulates particle formation in human cells: implications for alphavirus vaccine design","volume":"86","author":"Akahata","year":"2012","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.032_b0120","article-title":"Attenuation and stability of CHIKV-NoLS, a live-attenuated chikungunya virus vaccine candidate","volume":"7","author":"Abeyratne","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2023.05.032_b0125","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3389\/fimmu.2020.00304","article-title":"Liposomal delivery of the RNA genome of a live-attenuated chikungunya virus vaccine candidate provides local, but not systemic protection after one dose","volume":"11","author":"Abeyratne","year":"2020","journal-title":"Front Immunol"},{"issue":"16","key":"10.1016\/j.vaccine.2023.05.032_b0130","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.1128\/JVI.02603-09","article-title":"Chikungunya virus arthritis in adult wild-type mice","volume":"84","author":"Gardner","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.05.032_b0135","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.3389\/fimmu.2018.02469","article-title":"Regulation of the germinal center response","volume":"9","author":"Stebegg","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.032_b0140","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4049\/jimmunol.1202177","article-title":"A pathogenic role for CD4+ T cells during Chikungunya virus infection in mice","volume":"190","author":"Teo","year":"2013","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.032_b0145","doi-asserted-by":"crossref","DOI":"10.3390\/v13010054","article-title":"Lead SARS-CoV-2 candidate vaccines: expectations from phase III trials and recommendations post-vaccine approval","volume":"13","author":"Tumban","year":"2020","journal-title":"Viruses"},{"issue":"50","key":"10.1016\/j.vaccine.2023.05.032_b0150","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.15585\/mmwr.mm6950e2","article-title":"The advisory committee on immunization practices' interim recommendation for use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020","volume":"69","author":"Oliver","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2023.05.032_b0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41541-020-0159-8","article-title":"The promise of mRNA vaccines: a biotech and industrial perspective","volume":"5","author":"Jackson","year":"2020","journal-title":"NPJ Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2023.05.032_b0160","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201810092","article-title":"Mutating chikungunya virus non-structural protein produces potent live-attenuated vaccine candidate","volume":"11","author":"Chan","year":"2019","journal-title":"Embo Mol Med"},{"issue":"14","key":"10.1016\/j.vaccine.2023.05.032_b0165","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.160173","article-title":"Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera","volume":"7","author":"Roques","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.vaccine.2023.05.032_b0170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.645210","article-title":"Vaccine inoculation route modulates early immunity and consequently antigen-specific immune response","volume":"12","author":"Rosenbaum","year":"2021","journal-title":"Front Immunol"},{"issue":"suppl 5","key":"10.1016\/j.vaccine.2023.05.032_b0175","doi-asserted-by":"crossref","first-page":"S488","DOI":"10.1093\/infdis\/jiw271","article-title":"Development of vaccines for chikungunya fever","volume":"214","author":"Erasmus","year":"2016","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23005716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23005716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T07:37:58Z","timestamp":1718437078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23005716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":35,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0264410X23005716"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.05.032","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A booster regime of liposome-delivered live-attenuated CHIKV vaccine RNA genome protects against chikungunya virus disease in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}